Superior Planning, LLC’s Gilead Sciences GILD Stock Holding History

Superior Planning, LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$75.9K	Buy	+509	New	+$71.4K	0.03%	277

Other funds holding GILD

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Superior Planning, LLC's GILD Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Gilead Sciences (GILD) in Q3 2026: 509 shares worth $75.9K. The stake represents 0.03% of the portfolio and ranks #277 among its holdings.

1,774 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Superior Planning, LLC held 509 shares of Gilead Sciences worth $75.9K as of Q3 2026.
Gilead Sciences was a new Superior Planning, LLC position in Q3 2026.
Gilead Sciences made up 0.03% of Superior Planning, LLC's portfolio in Q3 2026, its #277 holding.
1,774 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.